# Study in Healthy Volunteers to Prove That Two Different Formulations of Rotigotine Patches Deliver Equivalent Drug Amount to the Body

> **NCT01059903** · PHASE1 · COMPLETED · sponsor: **UCB Pharma** · enrollment: 50 (actual)

## Conditions studied

- Healthy Volunteers

## Interventions

- **DRUG:** Rotigotine transdermal patch

## Key facts

- **NCT ID:** NCT01059903
- **Lead sponsor:** UCB Pharma
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-01
- **Primary completion:** 2010-02
- **Final completion:** 2010-03
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2012-05-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01059903

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01059903, "Study in Healthy Volunteers to Prove That Two Different Formulations of Rotigotine Patches Deliver Equivalent Drug Amount to the Body". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT01059903. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*